- Home
- SNV vs RVMD Comparison
SNV vs RVMD Comparison
Compare SNV & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNV
- RVMD
- Stock Information
- Founded
- SNV 1888
- RVMD 2014
- Country
- SNV United States
- RVMD United States
- Employees
- SNV N/A
- RVMD N/A
- Industry
- SNV Major Banks
- RVMD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SNV Finance
- RVMD Health Care
- Exchange
- SNV Nasdaq
- RVMD Nasdaq
- Market Cap
- SNV 7.8B
- RVMD 8.7B
- IPO Year
- SNV N/A
- RVMD 2020
- Fundamental
- Price
- SNV $56.25
- RVMD $42.32
- Analyst Decision
- SNV Buy
- RVMD Strong Buy
- Analyst Count
- SNV 19
- RVMD 13
- Target Price
- SNV $58.47
- RVMD $65.15
- AVG Volume (30 Days)
- SNV 1.4M
- RVMD 1.4M
- Earning Date
- SNV 01-15-2025
- RVMD 02-24-2025
- Dividend Yield
- SNV 2.69%
- RVMD N/A
- EPS Growth
- SNV N/A
- RVMD N/A
- EPS
- SNV 3.03
- RVMD N/A
- Revenue
- SNV $1,852,496,000.00
- RVMD $742,000.00
- Revenue This Year
- SNV N/A
- RVMD N/A
- Revenue Next Year
- SNV $6.71
- RVMD $1,855.56
- P/E Ratio
- SNV $18.17
- RVMD N/A
- Revenue Growth
- SNV N/A
- RVMD N/A
- 52 Week Low
- SNV $33.44
- RVMD $28.43
- 52 Week High
- SNV $59.92
- RVMD $62.40
- Technical
- Relative Strength Index (RSI)
- SNV 59.28
- RVMD 47.17
- Support Level
- SNV $53.96
- RVMD $41.62
- Resistance Level
- SNV $57.22
- RVMD $44.00
- Average True Range (ATR)
- SNV 1.34
- RVMD 1.47
- MACD
- SNV 0.16
- RVMD 0.48
- Stochastic Oscillator
- SNV 74.34
- RVMD 63.79
About SNV Synovus Financial Corp.
Synovus Financial Corp provides commercial and consumer banking in addition to a full suite of specialized products & services such as private banking, treasury management, wealth management, mortgage services, premium finance, asset-based lending, structured lending, capital markets, & international banking to clients through the wholly-owned subsidiary bank, Synovus Bank, and other offices in Alabama, Florida, Georgia, South Carolina, and Tennessee. It has four segments Wholesale Banking, Community Banking, Consumer Banking, and Financial Management Services, out of which the majority is from the Wholesale banking segment.
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio, and SOS1 and 4EBP1/mTORC1 programs.